SCHEMBL22319271

SCHEMBL22319271

O=C1CCCCCCCCCCCSC1

nearest known ligand 0.50

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
TRIM24 O15164 2/20 0.50
TRIM33 Q9UPN9 2/20 0.50
ALDH1A1 P00352 1/20 0.50
NOS3 P29474 1/20 0.30
NOS1 P29475 1/20 0.30
NOS2 P35228 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28411764 1.00 TRIM24 (0.50) TRIM24TRIM33ALDH1A1NOS3NOS1
SCHEMBL28983219 1.00
SCHEMBL22319295 1.00 TRIM24 (0.50) TRIM24TRIM33ALDH1A1NOS3NOS1
SCHEMBL22411156 1.00 TRIM24 (0.50) TRIM24TRIM33ALDH1A1NOS3NOS1
SCHEMBL22319272 1.00 TRIM24 (0.50) TRIM24TRIM33ALDH1A1NOS3NOS1
SCHEMBL28983231 1.00 TRIM24 (0.50) TRIM24TRIM33ALDH1A1NOS3NOS1
SCHEMBL10365968 0.97
SCHEMBL26447113 0.95 TRIM24 (0.50) TRIM24TRIM33ALDH1A1NOS3NOS1
SCHEMBL22319304 0.91 TRIM24 (0.48) TRIM24TRIM33ALDH1A1
SCHEMBL621262 0.89

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240368001-A1 SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2024-11-07 US disclosed
US-11987506-B2 Salt recovery solution and processes of use thereof AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2024-05-21 US disclosed
US-11826704-B2 Thermo-responsive solution, and method of use therefor AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2023-11-28 US disclosed
US-20230257284-A1 SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2023-08-17 US disclosed
CN-116282078-A Salt recovery solution and method of using the same 阿克福特斯技术有限公司 2023-06-23 CN disclosed
US-20230043356-A1 A SOLVENT DRYING COMPOSITION AND PROCESSES THEREFOR AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2023-02-09 US disclosed
CN-110099869-B Thermally responsive solution and method of use thereof 阿克福特斯技术有限公司 2022-12-06 CN disclosed
US-20220193608-A1 THERMO-RESPONSIVE SOLUTION, AND METHOD OF USE THEREFOR AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2022-06-23 US disclosed
US-20220185754-A1 AN ALCOHOL RECOVERY SOLUTION, AND METHOD OF USE THEREFOR AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2022-06-16 US disclosed
EP-3946712-A1 A SOLVENT DRYING COMPOSITION AND PROCESSES THERFOR Aquafortus Technologies Limited (NZ) 2022-02-09 EP disclosed
CN-113966322-A Alcohol recovery solution and use method thereof 艾克福特士技术有限公司 2022-01-21 CN disclosed
EP-3935035-A1 AN ALCOHOL RECOVERY SOLUTION, AND METHOD OF USE THEREFOR Aquafortus Technologies Limited (NZ) 2022-01-12 EP disclosed
US-11020706-B2 Thermo-responsive solution, and method of use therefor AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2021-06-01 US disclosed
WO-2020204733-A1 A SOLVENT DRYING COMPOSITION AND PROCESSES THERFOR AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2020-10-08 WO disclosed
US-20200308023-A1 SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2020-10-01 US disclosed
WO-2020185096-A1 AN ALCOHOL RECOVERY SOLUTION, AND METHOD OF USE THEREFOR AQUAFORTUS TECHNOLOGIES LIMITED (NZ) 2020-09-17 WO disclosed
EP-3691996-A2 A SALT RECOVERY SOLUTION AND PROCESSES OF USE THEREOF Aquafortus Technologies Limited (NZ) 2020-08-12 EP disclosed
CN-111225875-A Salt recovery solution and method of using salt recovery solution 阿克福特斯技术有限公司 2020-06-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11020706-B2 Thermo-responsive solution, and method of use therefor AQP1, SLC39A11, THEM6 TRIM24 3422/4885TRIM33 4450/4885ALDH1A1 1602/4885
US-20230043356-A1 A SOLVENT DRYING COMPOSITION AND PROCESSES THEREFOR AQP1, AQP4, NOTUM TRIM24 4597/4885TRIM33 4652/4885ALDH1A1 3984/4885
US-20220185754-A1 AN ALCOHOL RECOVERY SOLUTION, AND METHOD OF USE THEREFOR ADH1C, ADH1A, ADH5 TRIM24 2377/4885TRIM33 3982/4885ALDH1A1 12/4885
US-20220193608-A1 THERMO-RESPONSIVE SOLUTION, AND METHOD OF USE THEREFOR AQP1, SLC39A11, THEM6 TRIM24 3422/4885TRIM33 4450/4885ALDH1A1 1602/4885
US-11826704-B2 Thermo-responsive solution, and method of use therefor AQP1, SLC39A11, THEM6 TRIM24 3422/4885TRIM33 4450/4885ALDH1A1 1602/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.